Could Thoratec lose out after blood clot link?
This article was originally published in Clinica
Executive Summary
Thoratec’s market leading left ventricular assist device (LVAD) HeartMate II has been linked with an increase in blood clots in a recent study – potentially opening the heart pump field up to smaller rivals with next-generation devices.